Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ENSC

ENSC News

Newswire

08:18

Ensysce Biosciences shares surge 13.22% premarket after initiating enrollment in pivotal Phase 3 trial of PF614, its next-generation opioid with overdose protection.

08:07

Ensysce Biosciences Initiates PF614 Phase 3 Enrollment, Advances Opioid Towards Commercialization

08:22

Ensysce Biosciences shares rise 21.88% premarket after initiating pivotal Phase 3 trial of PF614 for post-surgical pain.

08:21

Ensysce Biosciences shares surge 12.46% premarket after initiating pivotal Phase 3 trial of PF614 for post-surgical pain.

08:03

India Denies Rice Dumping Allegations, Expert Says Demand Remains Robust Despite High Tariffs

View More

About ENSC

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More